What Happened?
Buffalo Grove, IL-based Phathom Pharmaceuticals Appointed Molly Henderson as Chief Financial and Business Officer
Date of management change: April 25, 2022
Buffalo Grove, IL-based Phathom Pharmaceuticals Appointed Molly Henderson as Chief Financial and Business Officer
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
Molly Henderson is Chief Financial and Business Officer at Phathom Pharmaceuticals. Previously, Molly held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Sayler Gerri, Wong David, Earls Bethany, Jackson Bill, Kim Susana, Miller Elias, Cone Sue, Terry Gina, Edwards Rory, Bouguermouh Salim, Yonenson Carrie
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.